SokoLife

SokoLife Regenerative biomaterials for surgery
ECM scaffolds for tissue repair
Clinical | Research
📩 [email protected]

06/20/2026

Looking forward to joining more than 20,000 biotech leaders, innovators, investors, and industry partners at the BIO International Convention in San Diego, June 22–25.

You’ll find SokoLife at the Oregon Pavilion, Booth #3243, alongside some of Oregon’s most innovative life sciences companies.

At SokoLife, we are developing next-generation biologically derived ECM biomaterials and tissue scaffolds for regenerative medicine, cardiovascular surgery, neurosurgery, wound care, and advanced tissue research.

Our mission is simple: transform natural tissues into reliable solutions that help advance research, improve patient outcomes, and expand access to innovative healthcare technologies worldwide.

We're actively looking to connect with strategic partners, distributors, research collaborators, investors, and organizations interested in advancing biomaterials and regenerative medicine technologies.

You can also find us through BIO Partnering™ and schedule a meeting in advance.

If you're attending BIO 2026, we'd love to connect.
Stop by Booth #3243 or reach out directly to schedule time with me.

Oregon’s life sciences ecosystem is growing fast, and we're proud to be part of the innovation happening here.

See you in San Diego!

04/17/2026

SokoLife has been awarded a $65K Small Business Sustainability Fund (SBSF) non-dilutive grant from Business Oregon - a strong validation of our mission.

This is more than funding - it’s a signal that what we’re building matters, and that the path we’re on is gaining real momentum.

At SokoLife, we’re developing next-generation ECM biomaterials for wound care, cardiovascular, and reconstructive surgery — with a focus on making them accessible, scalable, and globally impactful.

With this support, we’re accelerating:
- FDA pathway preparation
- expansion of our manufacturing capacity in Oregon
- readiness for global markets

From real-world clinical use to building a platform for the future of regenerative medicine - we’re just getting started.

Grateful for the strong support of biotech innovations businesses in Oregon’s ecosystem!

03/06/2026

Healing should do more than just close a wound - it should help the body regenerate.

At SokoLife, we’re developing next-generation ECM scaffolds designed to support real tissue repair and functional healing.
🔹 Derived from xenotissue-based extracellular matrix
🔹 Preserves the native collagen architecture
🔹 Maintains biomechanical strength and biocompatibility
🔹 Designed for applications in burns, traumatic injuries, and advanced wound care

More than a patch - our scaffold acts as a biological roadmap for integration, remodeling, and regeneration.

We’re excited to connect with clinicians, researchers, distributors, and innovators working in wound healing, regenerative medicine, and biomaterials.

📩 [email protected]
🌐 www.sokolife.us⁠
📞 +1 (541) 780-9595

⚠️ Regulatory note: This product is not yet FDA-cleared in the United States and is currently available for investigational or international clinical use only.

02/05/2026

In a recent complex open repair of an abdominal aortic aneurysm, our surgical team successfully performed vascular reconstruction using SokoLife’s GA-FIXED biological vascular graft.

This case highlights the growing role of biological vascular materials in supporting durable reconstruction, reliable blood flow restoration, and improved integration with host tissue. The procedure resulted in stable postoperative outcomes and effective perfusion of distal vessels.

Grateful to the surgical and clinical team from the Department of Vascular Surgery, National Institute of Surgery and Transplantology, for their expertise and commitment in managing some of the most challenging vascular cases.

Focused on advancing biological solutions in vascular and cardiovascular repair? 

Let’s connect:👉 https://calendly.com/cardiotissue/30min

Regulatory note: While this product is not yet FDA cleared in the United States, it is currently being applied in leading international clinics.

12/18/2025

Trooper Recovery, powered by SokoLife’s extracellular matrix (ECM) scaffold, supported healing in this complex reconstructive scenario.

In cases where donor-site closure after free fibular graft harvest is not feasible, thoughtful wound management becomes critical. Following reconstruction after a severe blast injury with a 16-cm humeral bone defect, a collagen-based ECM dressing was used to support granulation tissue formation and successful epithelialization at the donor site.

Grateful to the surgical and clinical teams of the A. A. Shalimov National Institute of Surgery and Transplantology for their expertise and commitment in managing some of the most challenging trauma cases.

Focused on complex wound healing? Let’s connect:
👉 https://calendly.com/cardiotissue/30min

Regulatory note: While this product is not yet FDA cleared in the United States, it is currently being applied in leading international clinics.

11/21/2025

SokoLife Contract Manufacturing - Cross-Linked Pericardium for Medical Devices

SokoLife is pleased to announce expanded contract manufacturing capabilities for glutaraldehyde-cross-linked bovine and porcine pericardium used in the development of heart valves, cardiovascular implants, and reconstructive surgical applications.

Our team supports medical device companies, research groups, and early-stage innovators with high-quality xenograft tissue processing that meets rigorous performance and regulatory standards.

Core Capabilities

• Glutaraldehyde cross-linking and anti-calcification treatments
• Controlled and verified tissue thickness (0.15–0.7 mm, custom ranges available)
• Custom sizing, surface inspection, and defect-free selection
• Sterilized tissue patches, temperature-controlled storage, and custom packaging
• Small-batch R&D production and scalable manufacturing

Quality & Compliance

All production is performed under an ISO 13485:2016 certified Quality Management System, following:
• FDA & USDA animal-derived material regulations
• ANSI/AAMI/ISO 22442-2 for sourcing and handling of animal tissues
• Full traceability and documentation for every batch

Sourcing Standards

The bovine pericardium used in SokoLife products is sourced exclusively from cattle raised in geographic regions classified by the World Organisation for Animal Health (WOAH) as having a Controlled Risk status for Bovine Spongiform Encephalopathy (BSE).

Delivery & Support

• Competitive pricing and flexible programs for startups and R&D teams
• Delivery timelines as fast as 3 days
• Technical support and collaboration from design through scale-up

---

Collaboration Invitation

We welcome discussions with companies developing cardiovascular devices, soft-tissue repair solutions, or regenerative medicine platforms, as well as academic and clinical partners exploring new applications for xenotissue biomaterials.

📩 To start a conversation or request specifications, please reach out:
📞 +1 (541) 780-9595
🌐 www.sokolife.us

 

10/30/2025

What if wound care didn’t just cover - but actually helped the body regenerate?

At SokoLife, we’re pioneering the next generation of ECM-based scaffolds that preserve native collagen architecture to enable functional healing, not just closure.

🔹 Sourced from decellularized bovine pericardium
🔹 Retains biomechanical strength and biocompatibility
🔹 Versatile applications - from burns to congenital heart repair
🔹 Produced under ISO 13485-certified processes

More than a patch - our scaffold is a biological roadmap for integration, remodeling, and true regeneration.

Whether you’re a clinician, researcher, distributor, or innovator in wound healing, cardiovascular surgery, or regenerative medicine - let’s connect.

📩 Together, we can make advanced healing accessible for the patients who need it most.

⚠️ Regulatory note: This product is not yet FDA-cleared for use in the United States and is currently available for investigational or international clinical use only.

📞 Contact us:
✉️ [email protected]
🌐 www.sokolife.us
📱 +1 (541) 780-9595

10/17/2025

Successful Ventriculo-Aortic Junction (VAJ) Reconstruction Using SokoLife’s GA-Fixed Bovine Pericardium

We’re proud to share a recent clinical success story: the use of SokoLife’s Glutaraldehyde (GA)-fixed bovine pericardium scaffold in complex cardiovascular reconstruction.

💡 In this case, the GA-fixed patch was used to restore the ventriculo-aortic junction (VAJ) in a patient with prosthetic endocarditis.

The result - complete recovery and no complications at 3-month follow-up -highlights the excellent biocompatibility, mechanical durability, and reliability of our xenotissue material.

This achievement reinforces our mission to make regenerative tissue solutions accessible to surgeons and patients worldwide.

Regulatory note: While this product is not yet FDA cleared in the USA, it is being successfully applied in leading international clinics.

At SokoLife, we provide scalable tissue solutions to support the development of valves, surgical devices, and regenerative applications.

👉 Let’s connect to explore collaboration opportunities.

📞 541-780-9595

🌐 www.sokolife.us

10/11/2025

What if tissue repair didn’t just cover wounds, but activated true regeneration?

At SokoLife, we’re redefining what’s possible in healing with our next-generation ECM-based scaffolds - engineered to do more than close wounds. We preserve the native collagen structure to guide complete, functional regeneration.

🧬 Why it matters:
✅ Sourced from decellularized xenotissue
✅ Maintains biomechanical strength and biocompatibility
✅ Designed for multi-indication use - from burns to congenital heart repair
✅ Produced under ISO 13485 manufacturing standards

Our scaffold isn’t just a patch - it’s a biological roadmap for tissue integration, remodeling, and regeneration.

Whether you're a clinician, researcher, or innovator in wound care, cardiovascular surgery, or reconstructive medicine - let’s connect.

📬 Let’s bring regenerative healing to the patients who need it most.
📩 Contact us:[email protected] | www.sokolife.us

10/03/2025

✨ Exciting durability milestone!

We’re proud to share that the aortic valve for TAVR, with leaflets manufactured using SokoLife’s glutaraldehyde-treated pericardium, has successfully completed 300 million durability test cycles ✅.

Tested under ISO 5840 standards, this result demonstrates the strength, reliability, and long-term resilience of our biomaterial for transcatheter heart valve applications.

At SokoLife, we’re committed to advancing cardiovascular innovation with affordable, high-quality biomaterials that enable the next generation of life-saving devices. 🌍❤️

We’d love to connect and explore collaborations!
📞 541-285-7575
🌐 www.sokolife.us

#

Address

1505 Franklin Boulevard
Eugene, OR
97403

Telephone

+15417809595

Website

Alerts

Be the first to know and let us send you an email when SokoLife posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to SokoLife:

Shortcuts

Share

Category